KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Ann

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors today

Related Keywords

Frankfurt , Brandenburg , Germany , Jarrod Aldom , Andrew Crockett , Andrea Zanichelli , Emel Ayg , Exchange Commission , Kalvista Pharmaceuticals Inc , Corporate Communications , University Hospital Frankfurt , Nasdaq , Kalvista Pharmaceuticals , Principal Investigator , San Donato , Chief Executive Officer , About Kalvista Pharmaceuticals , Vista Pharmaceuticals , Securities Litigation Reform Act , Marcel Torney , Kalvista , Pharmaceuticals , Nnounces , Publication , Sebetralstat , Hase , Data , Lancet ,